pubmed-article:19428827 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19428827 | lifeskim:mentions | umls-concept:C0034362 | lld:lifeskim |
pubmed-article:19428827 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
pubmed-article:19428827 | lifeskim:mentions | umls-concept:C0004340 | lld:lifeskim |
pubmed-article:19428827 | lifeskim:mentions | umls-concept:C0015737 | lld:lifeskim |
pubmed-article:19428827 | lifeskim:mentions | umls-concept:C2728259 | lld:lifeskim |
pubmed-article:19428827 | pubmed:issue | 14 | lld:pubmed |
pubmed-article:19428827 | pubmed:dateCreated | 2009-5-11 | lld:pubmed |
pubmed-article:19428827 | pubmed:abstractText | A nationally funded Q fever vaccination program was introduced in Australia in 2002. The evaluation of this unique program included measures of program uptake, safety, and notification and hospitalisation rates for Q fever pre- and post-program implementation. Program uptake ranged from close to 100% amongst abattoir workers to 43% in farmers. The most commonly reported adverse event was injection site reaction. Q fever notification rates declined by over 50% between 2002 and 2006, particularly in young adult males, consistent with the profile of the abattoir workforce. Hospitalisation data showed similar trends. Available evidence suggests a significant impact of Australia's Q fever vaccination program; such a program merits consideration in other countries with a comparable Q fever disease burden. | lld:pubmed |
pubmed-article:19428827 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19428827 | pubmed:language | eng | lld:pubmed |
pubmed-article:19428827 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19428827 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19428827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19428827 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19428827 | pubmed:month | Mar | lld:pubmed |
pubmed-article:19428827 | pubmed:issn | 0264-410X | lld:pubmed |
pubmed-article:19428827 | pubmed:author | pubmed-author:GiddingHeathe... | lld:pubmed |
pubmed-article:19428827 | pubmed:author | pubmed-author:McIntyrePeter... | lld:pubmed |
pubmed-article:19428827 | pubmed:author | pubmed-author:LawrenceGlend... | lld:pubmed |
pubmed-article:19428827 | pubmed:author | pubmed-author:WallaceCateC | lld:pubmed |
pubmed-article:19428827 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19428827 | pubmed:day | 23 | lld:pubmed |
pubmed-article:19428827 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:19428827 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19428827 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19428827 | pubmed:pagination | 2037-41 | lld:pubmed |
pubmed-article:19428827 | pubmed:dateRevised | 2009-7-8 | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:meshHeading | pubmed-meshheading:19428827... | lld:pubmed |
pubmed-article:19428827 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19428827 | pubmed:articleTitle | Australia's national Q fever vaccination program. | lld:pubmed |
pubmed-article:19428827 | pubmed:affiliation | National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Darlinghurst, New South Wales 2010, Australia. hgidding@nchecr.unsw.edu.au | lld:pubmed |
pubmed-article:19428827 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19428827 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19428827 | lld:pubmed |